Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald F Watts

Showing results (581-590 of 706) with videos related to

Pageof 71
Sort By:
European Heart Journal Open|July 2, 2026
Overview of methodology and characteristics of national acute coronary syndrome registries in high-income countries: a scoping reviewJustine Chan, Natalie Ward, Judith Finn, et al.
Journal of the American College of Cardiology|April 4, 2014
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumabErik Stroes, David Colquhoun, David Sullivan, et al.
Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.
Atherosclerosis|January 26, 2021
LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trialAntonio J Vallejo-Vaz, Chris J Packard, Brian A Ference, et al.
Social Science & Medicine (1982)|October 21, 2019
Predicting intention to participate in self-management behaviors in patients with Familial Hypercholesterolemia: A cross-national studyMartin S Hagger, Kyra Hamilton, Sarah J Hardcastle, et al.
Journal of the American College of Cardiology|February 15, 2020
Long-Term Evolocumab in Patients With Familial HypercholesterolemiaRaul D Santos, Evan A Stein, G Kees Hovingh, et al.
Lipids in Health and Disease|March 6, 2026
Lipoprotein(a), apolipoprotein B and other lipid biomarkers in Asian healthcare workersWann Jia Loh, Mon Hnin Tun, Brenda Shak, et al.
Metabolism: Clinical and Experimental|December 4, 2022
Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemiaGavin Huangfu, Biyanka Jaltotage, Jing Pang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 29, 2002
Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor bindingDairena Gaffney, Clive R Pullinger, Denis St J O'Reilly, et al.
Atherosclerosis|October 2, 2018
Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle adviceJing Pang, A David Marais, Dirk J Blom, et al.
Pageof 71

Showing results (581-590 of 706) with videos related to

Sort By:
Pageof 71
European Heart Journal Open|July 2, 2026
Overview of methodology and characteristics of national acute coronary syndrome registries in high-income countries: a scoping reviewJustine Chan, Natalie Ward, Judith Finn, et al.
Journal of the American College of Cardiology|April 4, 2014
Anti-PCSK9 antibody effectively lowers cholesterol in patients with statin intolerance: the GAUSS-2 randomized, placebo-controlled phase 3 clinical trial of evolocumabErik Stroes, David Colquhoun, David Sullivan, et al.
Journal of the American Heart Association|October 25, 2024
Plasma Protein Biomarkers and Long-Term Cardiovascular Mortality Risk in Patients With Chronic Coronary Heart DiseaseRalph A H Stewart, Kristy P Robledo, Andrew M Tonkin, et al.
Atherosclerosis|January 26, 2021
LDL-cholesterol lowering and clinical outcomes in hypercholesterolemic subjects with and without a familial hypercholesterolemia phenotype: Analysis from the secondary prevention 4S trialAntonio J Vallejo-Vaz, Chris J Packard, Brian A Ference, et al.
Social Science & Medicine (1982)|October 21, 2019
Predicting intention to participate in self-management behaviors in patients with Familial Hypercholesterolemia: A cross-national studyMartin S Hagger, Kyra Hamilton, Sarah J Hardcastle, et al.
Journal of the American College of Cardiology|February 15, 2020
Long-Term Evolocumab in Patients With Familial HypercholesterolemiaRaul D Santos, Evan A Stein, G Kees Hovingh, et al.
Lipids in Health and Disease|March 6, 2026
Lipoprotein(a), apolipoprotein B and other lipid biomarkers in Asian healthcare workersWann Jia Loh, Mon Hnin Tun, Brenda Shak, et al.
Metabolism: Clinical and Experimental|December 4, 2022
Hepatic fat as a novel marker for high-risk coronary atherosclerotic plaque features in familial hypercholesterolaemiaGavin Huangfu, Biyanka Jaltotage, Jing Pang, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|May 29, 2002
Influence of an asparagine to lysine mutation at amino acid 3516 of apolipoprotein B on low-density lipoprotein receptor bindingDairena Gaffney, Clive R Pullinger, Denis St J O'Reilly, et al.
Atherosclerosis|October 2, 2018
Heterozygous familial hypercholesterolaemia in specialist centres in South Africa, Australia and Brazil: Importance of early detection and lifestyle adviceJing Pang, A David Marais, Dirk J Blom, et al.
Pageof 71